Differential binding and activation of caspase-3 in cultured hippocampal neurons by assembly forms of Aβ1-42

Journal of Neuroscience Research

Volumn 85, Issue 6, 2007, Pages 1205-1214

  St John, Paul A ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

amyloid; Alzheimer's disease; Apoptosis; Caspase 3; Fibril; Hippocampus

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CASPASE 3;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BINDING; ENZYME LOCALIZATION; FIBER; HIPPOCAMPUS; MORPHOLOGY; NERVE CELL CULTURE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; CASPASE 3; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; ENZYME ACTIVATION; HIPPOCAMPUS; MICROSCOPY, ELECTRON; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SENILE PLAQUES;

EID: 34248185976     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21251     Document Type: Article

References (58)

1. Adamec E, Vonsattel JP, Nixon RA. 1999. DNA strand breaks in Alzheimer's disease. Brain Res 849:67-77.
2. Awasthi A, Matsunaga Y, Yamada T. 2005. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol 196:282-289.
3. 1-42 oligomer - a homogeneous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95:834-847.
4. Blanchard BJ, Chen A, Rozeboom LM, Stafford KA, Weigele P, Ingram VM. 2004. Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule. Proc Natl Acad Sci U S A 101:14326-14332.
5. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yatest J, Cotman C, Glabe C. 1992. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 267:546-554.
6. Cribbs DH, Poon WW, Rissman RA, Blurton-Jones M. 2004. Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol 165:353-355.
7. Dahlgren KN, Manelli AM, Stine WB, Baker LK, Krafft GA, LaDu MJ. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277:32046-32053.
8. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. 2005. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294-17300.
9. Deshpende A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26:6011-6018.
10. Desjardins P, Ledoux S. 1998. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex. Neurosci Lett 244:69-72.
11. Eckert A, Marques CA, Keil U, Schussel K, Muller WE. 2003. Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann N Y Acad Sci 1010:604-609.
12. Gastard MC, Troncoso JC, Koliatsos VE. 2003. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 54:393-398.
13. Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, Robertson GS, Slack RS, Park DS. 2000. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem 275:11553-11560.
14. 1-42 peptide is cell type dependent. J Neurochem 65:292-300.
15. Harada J, Sugimoto M. 1999. Activation of caspase-3 in β-amyloid-induced apoptosis of cultured rat cortical neurons. Brain Res 842:311-323.
16. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
17. Harper JD, Wong SS, Lieber CM, Lansbury PT. 1997. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem Biol 4:119-125.
18. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. 1999. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884.
19. Howlett DR, Jennings KH, Lee DC, Clark MSG, Brown F, Wetzel R, Wood SJ, Camilleri P, Roberts GW. 1995. Aggregation state and neurotoxic properties of Alzheimer beta-amyloid peptide. Neurodegeneration 4:23-32.
20. Hwang DY, Chae KR, Kang TS, Hwang JH, Lim CH, Kang HK, Goo JS, Lee MR, Lim HJ, Min SH, Cho JY, Hong JT, Song CW, Paik SG, Cho JS, Kim YK. 2002. Alterations in behavior, amyloid β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease. FASEB J 16:805-813.
21. Jarrett JT, Berger EP, Lansbury PT. 1993. The carboxy terminus of the amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
22. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489.
23. Klein WL. 2002. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41:345-352.
24. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL. 2004. Synaptic targeting by Alzheimer's-related amyloid β oligomers. J Neurosci 24:10191-10200.
25. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G. 1995. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 9:21-30.
26. 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95:6448-6453.
27. Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Ventou DL, Krafft GA, Finch CE, Klein WL. 2001. Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies. J Neurochem 79:595-605.
28. Li Y-P, Bushnell AF, Lee C-M, Purlmutter LS, Wong SK-F. 1996. β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 738:196-204.
29. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. 1993. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 90:7951-7955.
30. Lorenzo A, Yankner BA. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A 91:12243-12247.
31. Marin N, Romero B, Bosch-Morell F, Llansola M, Felipo V, Roma J. Romero FJ. 2000. β-Amyloid-induced activation of caspase-3 in primary cultures of rat neurons. Mech Ageing Dev 119:63-67.
32. Masumura M, Hata R, Nishimura I, Uetsuki T, Sawada T, Yoshikawa K. 2000. Caspase-3 activation and inflammatory responses in rat hippocampus inoculated with a recombinant adenovirus expressing the Alzheimer amyloid precursor protein. Brain Res Mol Brain Res 80:219-227.
33. Matsui T, Ramasamy K, Ingelsson M, Fukumoto H, Conrad C, Frosch MP, Irizarry MC, Yuan J, Hyman BT. 2006. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable Aβ42 levels. J Neuropathol Exp Neurol 65:508-515.
34. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. 1991. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314.
35. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
36. Raina AK, Hochman A, Zhu X, Rottkamp CA, Nunomura A, Siedlak SL, Boux H, Castellani RJ, Perry G, Smith MA. 2001. Abortive apoptosis in Alzheimer's disease. Acta Neuropathol 101:305-310.
37. 2+ channel currents in primary cultures of rat cortical neurons by amyloid β protein (1-40) is dependent on solubility status. Brain Res 956:254-261.
38. Seilheimer B, Bohrmann B, Bondolfi L, Muller F, Stuber D, Dobeli H. 1997. The toxicity of the Alzheimer's β-amyloid peptide correlates with a distinct fiber morphology. J Struct Biol 119:59-71.
39. Selkoe DJ. 2001. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
40. Selznick LA, Holtzman DM, Han BH, Gokden M, Srinivasan AN, Johnson EM, Roth KA. 1999. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 58:1020-1026.
41. Shimohama S, Tanino H, Fujimoto S. 1999. Changes in caspase expression in Alzheimer's disease: comparison with development and aging. Biochem Biophys Res Commun 256:381-384.
42. Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN. 1994. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
43. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE. 1995. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 133:225-230.
44. St. John PA, Froehner SC, Goodenough DA, Cohen JB. 1982. Nicotinic postsynaptic membranes from Torpedo: sidedness, permeability to macromolecules, and topography of major polypeptides. J Cell Biol 92:333-342.
45. Stine WB, Dahlgren KN, Krafft GA, LaDu MJ. 2003. In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612-11622.
46. Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW. 2001. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology. Brain Res 898:350-357.
47. Takuma H, Tomiyama T, Kuida K, Mori H. 2004. Amyloid beta peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo. J Neuropathol Exp Neurol 63:255-261.
48. Troy CM, Rabacchi SA, Friedman WJ, Farppier TF, Brown K, Shelanski ML. 2000. Caspase-2 mediates neuronal cell death induced by β-amyloid. J Neurosci 20:1386-1392.
49. Walsh DM, Lomakin A, Benedek GB, Condron MM, Teplow DB. 1997. Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem 272:22364-22372.
50. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, Lomakin A, Benedek GB, Slekoe DJ, Teplow DB. 1999. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274:25945-25952.
51. Watt JA, Pike CJ, Walencewicz-Wasserman, Cotman CW. 1994. Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res 661:147-156.
52. West MJ, Coleman PD, Flood DG, Troncoso JC. 1994. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772.
53. West MJ, Kawas CH, Martin LJ, Troncoso JC. 2000. The CA1 region of the human hippocampus is a hot spot in Alzheimer's disease. Ann N Y Acad Sci255-259.
54. Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, Ruther E, Kornhuber J. 2002. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81:481-496.
55. Yankner BA. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932.
56. Ye C, Walsh DM, Selkoe DJ, Hartley DM. 2004. Amyloid β-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation. Neurosci Lett 366:320-325.
57. Younkin SG. 1998. The role of Aβ42 in Alzheimer's disease. J Physiol (Paris) 92:289-292.
58. Zhang Y, Goodyer C, LeBlanc A. 2000. Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci 20:8384-8389.